AustinPx

As the excitement builds for AAPS PharmSci 360, AustinPx is looking forward to diving deeper into the emerging trends in drug formulation, targeted therapeutics, and leveraging AI in drug development. We know that now, more than ever, accelerating the drug development timeline while maintaining quality is critical to advancing patient care. If you’re interested in learning how we can help you navigate the challenges of formulation and bioavailability enhancement, let's connect during the event. Schedule a meeting with us to discuss how we can collaborate to advance your drug development goals. Visit: www.austinpx.com/AAPS-2024 #AAPS2024 #PharmaInnovation #DrugDevelopment #CDMO #Bioavailability #PharmaceuticalScience

Happy National Chemistry Week! At AustinPx, we know that behind every breakthrough in drug development, there’s a deep understanding of chemistry. From enhancing the bioavailability of complex compounds to innovating sustainable manufacturing practices, chemistry is at the core of everything we do. As we celebrate the role of chemistry in improving lives, we want to acknowledge the brilliant scientists who are shaping the future of pharmaceuticals. Here’s to pushing the boundaries of what’s possible through chemistry—today and every day. Let’s keep the innovation going! #NationalChemistryWeek #Pharmaceuticals #Innovation #ChemistryInAction #SustainableScience #DrugDevelopment

I am incredibly honored to share that AustinPx has won in the Accelerating Innovation category at the CPHI Pharma Awards, thanks to the groundbreaking work we've done with KinetiSol! This recognition reflects the impact KinetiSol has had in transforming drug manufacturing, particularly in enhancing bioavailability while also significantly reducing our environmental footprint. By eliminating the need for harmful solvents, KinetiSol stands at the intersection of pharmaceutical innovation and sustainability, offering a greener alternative without compromising on efficiency or quality. It’s an exciting time for us, and I’m eager to continue pushing boundaries and collaborating with others who are equally passionate about improving drug development processes. #CPHI2024 #AcceleratingInnovation #Sustainability #KinetiSol #PharmaceuticalManufacturing #Bioavailability #PharmaInnovation #AustinPx #CDMO

AustinPx is excited to announce that our Sr. Director of Business Development, Collin Burger, will be attending AAPS 2024 PHARMSCI 360 from October 20-23, 2024 in Salt Lake City, UT. With a strong focus on the future of drug development, Collin will be available to offer insights into how our work is shaping the path to more efficient, innovative therapies. This event offers a prime opportunity to discuss how the latest advances in AI, bioavailability, and targeted therapeutics are transforming the pharmaceutical landscape. We look forward to sharing our perspective and learning from the broader industry dialogue. To meet with Collin and explore potential collaborations, visit www.austinpx.com/AAPS-2024. #AAPS2024 #PharmaInnovation #DrugDevelopment #CDMO #Bioavailability #PharmaceuticalScience

As we gear up for CPHI 2024 in Milan, AustinPx is excited to be part of the conversations shaping the future of pharmaceutical innovation. With the industry facing challenges in drug development, manufacturing, and regulatory frameworks, now more than ever, collaboration is key. Our team will be attending #CPHI2024 to connect with global leaders and explore new ways to overcome these challenges. Interested in learning how our capabilities in bioavailability enhancement and advanced manufacturing can accelerate your projects? Schedule a meeting with us and discover how we can help you navigate these complexities. Visit: https://lnkd.in/gkJgP5MD. #CPHI2024 #Milan #PharmaInnovation #PharmaManufacturing #AustinPx #CDMO #Bioavailability #PharmaceuticalDevelopment

Happy National Manufacturing Day! At AustinPx, we’re proud to be at the forefront of transforming challenging compounds into high-quality treatments. Recently, our Sr. VP of Operations, Justin Keen, Ph.D., showcased our cutting-edge GMP manufacturing suites, offering a glimpse into the advanced facilities and processes that set us apart in drug product development. With over 15 years of experience, we’re committed to accelerating clinical timelines and delivering breakthrough solutions that get treatments to patients faster. Here's to the future of pharmaceutical manufacturing! #ManufacturingDay #PharmaInnovation #GMP #DrugDevelopment #AustinPx #ManufacturingExcellence

From October 8 to 10, AustinPx will join the global pharmaceutical community at CPHI 2024 in Milan, Italy. Schedule a meeting with one of our experts to discover how we can support your pharmaceutical product pipeline through innovative drug development and manufacturing solutions. Who will be attending? Elizabeth Hickman, Chief Business Officer Rob Rigney, Senior Director of Business Development Daniel Davis, Ph.D., PharmD, Principal Scientist   Our team is excited to connect with industry leaders and discuss how our unique technologies, including KinetiSol®, are advancing drug bioavailability and sustainability in pharmaceutical manufacturing. Schedule a meeting here: www.austinpx.com/CPHI-2024    #CPHI2024 #Milan #PharmaInnovation #PharmaManufacturing #AustinPx #CDMO #Bioavailability #PharmaceuticalDevelopment

AustinPx is excited to announce an upcoming webinar on October 1st at 1pm EDT, focusing on overcoming the challenges of scaling up Amorphous Solid Dispersions (ASDs). Join Justin Keen, Senior VP of Operations at AustinPx, and TJ Higley, CEO at Microsize, as they share best practices for tech transfer and explore improvements in scalability using next-generation technologies like KinetiSol™. The session will also cover common challenges, including feed rate variability, particle size control, and material sustainability. If you're looking to optimize your ASD development and tackle scale-up challenges, this webinar is for you! Reserve your spot now and gain valuable insights from industry experts: https://lnkd.in/gPi8UTti. #PharmaInnovation #KinetiSol #ASD #TechTransfer #PharmaManufacturing #SustainableTech #DrugDevelopment

Meet Sofia Figueroa, a dedicated scientist on our Pharmaceutics team helping to advance our client's programs to the clinic. Sofia specializes in developing amorphous solid dispersions and uses advanced techniques like dissolution, DSC, and HPLC to ensure each formulation is optimized. The work that she does is key to solving complex challenges and driving data-driven decisions for our clients.   Sofia thrives in the dynamic environment of the lab, where no two days are the same. She values the opportunity to experiment with new ideas and appreciates the fast pace that keeps her continually learning and growing. She notes that her "commitment to making a positive impact through groundbreaking technology motivates her every step of the way".   Discover how Sofia’s expertise is shaping the future of pharmaceutics: https://lnkd.in/gyrVRcPY. #EmployeeSpotlight #AmorphousDispersions #Pharma #Innovation #ASD

Happy Zero Emissions Day! At AustinPx we’re proud to help our clients on their sustainability journey, supporting efforts to reduce their carbon footprint and drive innovation in pharmaceutical development. In just two years, we’ve had the privilege of working with more than 30 clients to explore more sustainable amorphous dispersion development programs, helping them potentially eliminate thousands of metric tons of solvent from their supply chain each year. Let’s keep pushing boundaries and build a more sustainable future, one molecule at a time. #Sustainability #PharmaceuticalDevelopment #KinetiSol #Innovation #SolventFree #CDMO #GreenPharma